SAT0085 A study on characteristics of rheumatoid arthritis patients achieving depression remission with 6 months of biologic agent treatment

• Published in: Annals of the rheumatic diseases Vol. 76; no. Suppl 2; pp. 800 - 801
• Main Authors: Miwa, Y, Yajima, N, Isozaki, T, Takahashi, R, Miura, Y, Ikari, Y, Hatano, M, Hayashi, T, Kasama, T, Sanada, K
• Format: Journal Article
• Language: English
• Published: Kidlington Elsevier Limited 01.06.2017
• Subjects: Activities of daily living; Age; Long-term depression; Matrix metalloproteinase; Mental depression; Metalloproteinase; Methotrexate; Patients; Quality of life; Remission; Rheumatoid arthritis; Stromelysin 1; Japan

BackgroundApproximately 15% of RA patients also suffer from depression, with an odds ratio of 1.42 (95% CI 1.3 - 1.5) compared with healthy people. A previous study reported that biological agents can improve the depressed state associated with RA. Although previous studies have been cross-sectional...